This is Work in Progress, a newsletter by Derek Thompson about work, technology, and how to solve some of America’s biggest problems. Sign up here to get it every week. In 2013, researchers at Oxford published an analysis of the jobs most likely to be threatened by automation and artificial intelligence. At the top of … Read more
WALTHAM, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that the company will host a live virtual program on Thursday, December 1, 2022, at 12:30 pm ET spotlighting Xilio’s clinical-stage molecule XTX301, a tumor-activated, engineered IL-12. The … Read more